| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,516 |
1,326 |
$137K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,118 |
1,002 |
$78K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,173 |
1,066 |
$56K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
486 |
478 |
$44K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
229 |
208 |
$6K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
41 |
41 |
$6K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
192 |
95 |
$3K |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
13 |
13 |
$177.12 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
50 |
42 |
$88.29 |